Team:Rutgers/Safety

From 2012.igem.org

Revision as of 04:45, 2 October 2012 by SanaWajid (Talk | contribs)

Rutgers 2012 iGEM Team: Biofuels in Biology

Rutgers 2012 iGEM Team: Biofuels in Bacteria

I. Would any of your project ideas raise safety issues in terms of?

Researcher Safety
Use of hazardous chemicals: Ethidium Bromide (EtBr)

Public Safety 
None

Environmental Safety? 
None

Security Threats? 
None

Our projects are involved with Butanol pathways and light detection. By themselves they pose no risk to anyone. Although the yield of 1-Butanol must be handled with caution due to its flammability.

II. Do any of the new biobrick parts (or devices) that you made this year raise any safety issues? If yes,

For the parts that are already in the registry no safety issues have been encountered.  The five BioBrick parts we are creating from scratch are transcriptional regulators and genes which should not raise any safety issues

III. UNDER WHAT BIOSAFETY PROVISIONS WILL / DO YOU OPERATE?

Does your institution have its own biosafety rules and if so what are they? Provide a link to them online if possible. 

Rutgers Environmental Health and Safety (REHS) regulates protocols and waste disposal methods used by federally funded research projects. (REHS:http://rehs.rutgers.edu/lsbio_comm.html)


Is there a local biosafety group, committee, or review board at your institution?

REHS provides oversight and training for various hazards such as medical waste, hazardous waste, and radioactive waste. Dr Vershon, our PI, reviewed our project for possible safety issues; he did not find any. He also informed us of the labs procedures for disposing waste and general safety procedures. 

The procedures have all been reviewed by REHS and are approved under the Recombinant DNA RD-00-029 (11/28/2000 – 12/31/2015) issued to Dr. Vershon by REHS.


Does your country have national biosafety regulations or guidelines? If so, provide a link to them online if possible. 

Yes, the NIH has guidelines for biosafety available here:
http://oba.od.nih.gov/oba/rac/guidelines_02/NIH_Gdlnes_lnk_2002z.pdf